{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,30]],"date-time":"2025-08-30T00:06:37Z","timestamp":1756512397787,"version":"3.44.0"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:00:00Z","timestamp":1756425600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>SMARCB1-deficient renal medullary carcinoma (RMC) is a rare and aggressive kidney cancer defined by the loss of SMARCB1 tumor suppressor and primarily affecting adolescents and young adults with sickle hemoglobinopathies. Approximately 7% of RMC cases, known as renal cell carcinoma unclassified with medullary phenotype (RCCU-MP), lack sickle hemoglobinopathy. RMC does not respond to immune checkpoint inhibitors and antiangiogenic tyrosine kinase inhibitors, with chemotherapy being the main treatment. Here we present the first documented case of RMC diagnosed during pregnancy. A 24-year-old woman presented with right-sided back pain, leading to the discovery of a 6-cm right renal mass. Pathology confirmed RCCU-MP with SMARCB1 loss. With the woman at 16 weeks into pregnancy, imaging revealed metastatic retroperitoneal lymphadenopathy and lung nodules. A chemotherapy regimen of doxorubicin and cyclophosphamide, followed by weekly paclitaxel, was selected for safety in pregnancy. This approach yielded significant tumor shrinkage and alleviated the symptoms, allowing for the safe, preterm delivery of a healthy baby at 33 weeks. Following delivery, the patient received combination chemotherapy and definitive radiation therapy, achieving disease control. At 2 years post-diagnosis, she remains alive, exceeding the median survival for RCCU-MP. This case demonstrates that established chemotherapeutic regimens used in pregnant patients with other cancers can be successfully applied to manage RMC during pregnancy. Our findings underscore the importance of early, aggressive treatment and suggest that a coordinated approach can achieve favorable outcomes for both the mother and the fetus.<\/jats:p>","DOI":"10.3389\/fonc.2025.1606647","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T16:47:41Z","timestamp":1756486061000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: Successful delivery following chemotherapy in a pregnant patient with metastatic SMARCB1-deficient renal medullary carcinoma"],"prefix":"10.3389","volume":"15","author":[{"given":"Panayiotis D.","family":"Kontoyiannis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Kuykendal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chad","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica P.","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beei","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan S.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priya","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bora","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pavlos","family":"Msaouel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,8,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.clgc.2018.09.005","article-title":"Updated recommendations on the diagnosis, management, and clinical trial eligibility criteria for patients with renal medullary carcinoma","volume":"17","author":"Msaouel","year":"2019","journal-title":"Clin Genitourin Cancer"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-17-3296","article-title":"Model linking sickle cell hemoglobinopathies and SMARCB1 loss in renal medullary carcinoma","volume":"24","author":"Msaouel","year":"2018","journal-title":"Clin Cancer Res"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.euo.2024.07.002","article-title":"Clinical characteristics, management, and outcomes of patients with renal medullary carcinoma: A single-center retrospective analysis of 135 patients","volume":"8","author":"Lebenthal","year":"2024","journal-title":"Eur Urol Oncol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2023.04.019","article-title":"Renal cell carcinoma of variant histology: biology and therapies","volume":"37","author":"Msaouel","year":"2023","journal-title":"Hematol Oncol Clin North Am"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3390\/curroncol30030255","article-title":"Renal cell carcinoma unclassified with medullary phenotype in a patient with neurofibromatosis type 2","volume":"30","author":"Sarkar","year":"2023","journal-title":"Curr Oncol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.ccell.2020.04.002","article-title":"Comprehensive molecular characterization identifies distinct genomic and immune hallmarks of renal medullary carcinoma","volume":"37","author":"Msaouel","year":"2020","journal-title":"Cancer Cell"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15153806","article-title":"Phase II clinical trial of pembrolizumab efficacy and safety in advanced renal medullary carcinoma","volume":"15","author":"Nze","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2209639120","article-title":"SMARCB1 regulates the hypoxic stress response in sickle cell trait","volume":"120","author":"Soeung","year":"2023","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.clgc.2024.102065","article-title":"Radiation therapy for the management of renal medullary carcinoma: A multi-case study","volume":"22","author":"Mbilinyi","year":"2024","journal-title":"Clin Genitourin Cancer"},{"key":"B10","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/j.ccell.2022.07.006","article-title":"Precise reconstruction of the TME using bulk RNA-seq and a machine learning algorithm trained on artificial transcriptomes","volume":"40","author":"Zaitsev","year":"2022","journal-title":"Cancer Cell"},{"key":"B11","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.ccell.2024.02.001","article-title":"Multi-omic profiling of follicular lymphoma reveals changes in tissue architecture and enhanced stromal remodeling in high-risk patients","volume":"42","author":"Radtke","year":"2024","journal-title":"Cancer Cell"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-025-01929-w","article-title":"A novel case of glial transdifferentiation in renal medullary carcinoma brain metastasis","volume":"13","author":"Gubbiotti","year":"2025","journal-title":"Acta Neuropathol Commun"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12123616","article-title":"Update on the management of breast cancer during pregnancy","volume":"12","author":"Poggio","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B14","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.clbc.2023.11.007","article-title":"Weekly paclitaxel for pregnancy associated breast cancer","volume":"24","author":"Girardelli","year":"2024","journal-title":"Clin Breast Cancer"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.clgc.2021.08.007","article-title":"Efficacy and safety of gemcitabine plus doxorubicin in patients with renal medullary carcinoma","volume":"19","author":"Wilson","year":"2021","journal-title":"Clin Genitourin Cancer"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1111\/bju.13705","article-title":"Management and outcomes of patients with renal medullary carcinoma: a multicentre collaborative study","volume":"120","author":"Shah","year":"2017","journal-title":"BJU Int"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1080\/23723556.2020.1777060","article-title":"Molecular hallmarks of renal medullary carcinoma: more to c-MYC than meets the eye","volume":"7","author":"Msaouel","year":"2020","journal-title":"Mol Cell Oncol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.31578","article-title":"The classification of pediatric and young adult renal cell carcinomas registered on the children\u2019s oncology group (COG) protocol AREN03B2 after focused genetic testing","volume":"124","author":"Cajaiba","year":"2018","journal-title":"Cancer"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14133103","article-title":"Transplacental passage and fetal effects of antineoplastic treatment during pregnancy","volume":"14","author":"Triarico","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1111\/IGC.0b013e3181fb18c8","article-title":"Transplacental transfer of paclitaxel, docetaxel, carboplatin, and trastuzumab in a baboon model","volume":"20","author":"Calsteren","year":"2010","journal-title":"Int J Gynecol Cancer"},{"key":"B21","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3390\/genes7080051","article-title":"Targeting DNA replication stress for cancer therapy","volume":"7","author":"Zhang","year":"2016","journal-title":"Genes (Basel)"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27154736","article-title":"Targeting replication stress response pathways to enhance genotoxic chemo- and radiotherapy","volume":"27","author":"Nickoloff","year":"2022","journal-title":"Molecules"},{"key":"B23","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1055\/s-0034-1368091","article-title":"Administration of gemcitabine for metastatic adenocarcinoma during pregnancy: A case report and review of the literature","volume":"4","author":"Wiesweg","year":"2014","journal-title":"AJP Rep"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2007.06.017","article-title":"Docetaxel, gemcitabine, and cisplatin administered for non-small cell lung cancer during the first and second trimester of an unrecognized pregnancy","volume":"59","author":"Kim","year":"2008","journal-title":"Lung Cancer"},{"key":"B25","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ajog.2013.12.002","article-title":"Cancer and pregnancy: an overview for obstetricians and gynecologists","volume":"211","author":"Salani","year":"2014","journal-title":"Am J Obstet Gynecol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000004899","article-title":"Chemotherapy against cancer during pregnancy: A systematic review on neonatal outcomes","volume":"95","author":"Esposito","year":"2016","journal-title":"Med (Baltimore)"},{"key":"B27","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.ygyno.2010.08.019","article-title":"Transplacental transfer of anthracyclines, vinblastine, and 4-hydroxy-cyclophosphamide in a baboon model","volume":"119","author":"Van Calsteren","year":"2010","journal-title":"Gynecol Oncol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(05)70169-8","article-title":"Radiotherapy during pregnancy: fact and fiction","volume":"6","author":"Kal","year":"2005","journal-title":"Lancet Oncol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1606647\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T16:47:41Z","timestamp":1756486061000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1606647\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,29]]},"references-count":28,"alternative-id":["10.3389\/fonc.2025.1606647"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1606647","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,29]]},"article-number":"1606647"}}